17136-36-6
17136-36-6
Chemical Structure
2-(Benzylamino)acetic acid
- CAS No.: 17136-36-6
- Formula:C9H11NO2
- Molecular Weight:165.19
IUPAC Name: 2-(Benzylamino)acetic acid
InChIKey: KGSVNOLLROCJQM-UHFFFAOYSA-N
SMILES: O=C(O)CNCC1=CC=CC=C1
Biological Activity: 2-(Benzylamino)acetic acid is a Glycine (HY-Y0966) derivative[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
2-(Benzylamino)acetic acid | 98.46% | 2-(Benzylamino)acetic acid is a Glycine (HY-Y0966) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Phenylbutyric acid | 99.98% | 4-Phenylbutyric acid (4-PBA) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Benzylglycine ethyl ester | 98.61% | N-Benzylglycine ethyl ester is an N-substituted glycine derivative. N-Benzylglycine ethyl ester is bound to PDB code: 1B41. N-Benzylglycine ethyl ester can be used in Alzheimer's disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Phenylacetylglycine (Standard) | 99.38% | Phenylacetylglycine (Standard) is the analytical standard of Phenylacetylglycine. This product is intended for research and analytical applications. Phenylacetylglycine is a gut microbial metabolite that can activate β2AR. Phenylacetylglycine protects against cardiac injury caused by ischemia/reperfusion. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hippuric acid (Standard) | 99.79% | Hippuric acid (Standard) is the analytical standard of Hippuric acid. This product is intended for research and analytical applications. Hippuric Acid is an orally active metabolite. Hippuric Acid can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Hippuric Acid decreases NRF2, MMP9 and leads to ROS accumulation. Hippuric Acid activates TGFβ/SMAD signaling. Hippuric Acid improves hyperuricemia and colitis. Hippuric Acid can also be used in cardiovascular disease research. . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hippuric acid-15N | Hippuric acid-15N is the 15N-labeled Hippuric acid. Hippuric Acid (2-Benzamidoacetic acid), an acyl glycine produced by the conjugation of benzoic acid and glycine, is a normal component in urine as a metabolite of aromatic compounds from food. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Benzyl-L-serine | 99.98% | Benzyl-L-serine is a serine derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hippuric acid-13C6 | 99.90% | Hippuric acid-13C6 (Benzoylglycine-13C6) is 13C labeled Hippuric acid. Hippuric Acid is an orally active metabolite. Hippuric Acid can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Hippuric Acid decreases NRF2, MMP9 and leads to ROS accumulation. Hippuric Acid activates TGFβ/SMAD signaling. Hippuric Acid improves hyperuricemia and colitis. Hippuric Acid can also be used in cardiovascular disease research. . | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
N-Benzylglycine hydrochloride | 99.95% | N-Benzylglycine hydrochloride is a Glycine (HY-Y0966) derivative. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hydrocinnamic acid (Standard) | ≥98% | Hydrocinnamic acid (Standard) is the analytical standard of Hydrocinnamic acid. This product is intended for research and analytical applications. Hydrocinnamic acid is the major rhizospheric compound with known growth regulatory activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Hydrocinnamic acid-2,3-13C2 | Hydrocinnamic acid-2,3-13C2 is the 13C-labeled Hydrocinnamic acid. Hydrocinnamic acid is the major rhizospheric compound with known growth regulatory activities. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
